ArticleO&G open2026
Patient Satisfaction With a Novel Postcoital Intravaginal Fluid-Absorbing Device.
Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06530186 (Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate patient-reported symptom outcomes, usability, and vaginal pH after use of a postcoital intravaginal fluid-absorbing device.
methodsIn this prospective cohort study, adult women who were sexually active with male partners used a postcoital intravaginal fluid-absorbing device after intercourse. Participants completed baseline symptom assessments and a postuse questionnaire evaluating discharge, odor, usability, and likelihood of reuse. A subset performed paired vaginal pH measurements at baseline and at 2-6 and 10-14 hours after intercourse under two conditions: intercourse without the device and intercourse followed by device use. Paired
resultsA total of 542 participants enrolled; 291 (53.7%) completed the postuse questionnaire. Baseline postcoital symptoms were common, including discharge or dripping (87.6%), vaginal odor (64.9%), and a sensation of feeling unclean (58.1%). Among respondents, 98.0% reported improvement in postcoital discharge and 84.3% reported improvement in vaginal odor after device use. Most participants reported they would use the product again (93.1%) and recommend it to others (94.2%). Usability ratings were favorable, with 88.3% reporting ease of insertion and 93.1% reporting ease of removal. In the paired pH subset (n=48), mean vaginal pH was lower with device use compared with no device at 2-6 hours (5.2±0.9 vs 5.5±0.9,
conclusionUse of a postcoital intravaginal fluid-absorbing device was associated with improvement in patient-reported postcoital discharge and odor, high user acceptability, and lower vaginal pH after intercourse. These findings support further evaluation of nonpharmacologic approaches to managing common postcoital gynecologic symptoms. CLINICAL
trial registrationClinicalTrials.gov, NCT06530186.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.